Informationen:
Fehler:
ID
26006
Beschreibung
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00389155
Link
https://clinicaltrials.gov/show/NCT00389155
Stichworte
Versionen (2)
- 02.10.17 02.10.17 -
- 04.10.17 04.10.17 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
4. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Bladder Cancer NCT00389155
Eligibility Bladder Cancer NCT00389155
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Bladder Cancer NCT00389155
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Transitional cell carcinoma of the urothelial tract Advanced Locally | Transitional cell carcinoma of the urothelial tract metastatic
Item
clinical diagnosis of transitional cell carcinoma of the urothelium that is locally advanced or metastatic
boolean
C2145472 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C2145472 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C2145472 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
Therapeutic procedure Cisplatin Based | Patient Ineligible
Item
ineligible for cisplatin-based therapy because of at least one of the following two medical conditions:
boolean
C0087111 (UMLS CUI [1,1])
C0008838 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1512714 (UMLS CUI [2,2])
C0008838 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1512714 (UMLS CUI [2,2])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
calculated creatinine clearance ≤60 ml/min: or
boolean
C2711451 (UMLS CUI [1])
Congestive heart failure New York Heart Association Classification
Item
new york heart association classification stage iii-iv congestive heart failure
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Measurable Disease | Lesion Linear Quantity Imaging
Item
measurable disease documented by imaging with at least one uni-dimensional lesion
boolean
C1513041 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C0205132 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0011923 (UMLS CUI [2,4])
C0221198 (UMLS CUI [2,1])
C0205132 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0011923 (UMLS CUI [2,4])
ECOG performance status
Item
adequate performance status (ecog 0, 1, or 2)
boolean
C1520224 (UMLS CUI [1])
Age
Item
men and women ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
Indication Therapeutic radiology procedure | Indication Operative Surgical Procedures
Item
patients in whom radiation or surgery is indicated
boolean
C3146298 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
C1522449 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0543467 (UMLS CUI [2,2])
Neuropathy CTCAE Grades
Item
current neuropathy ≥ ctcae grade 3
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Therapeutic radiology procedure Bone Marrow Percentage
Item
prior radiation to ≥ 30% of bone marrow
boolean
C1522449 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Abnormal renal function | Creatinine clearance measurement
Item
inadequate renal function: serum creatinine clearance ≤ 20 ml/min
boolean
C0151746 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
Vinca alkaloid allergy
Item
prior allergy to any vinca alkaloid
boolean
C0570714 (UMLS CUI [1])